Is it safe for a patient on a GLP‑1 receptor agonist (e.g., semaglutide, liraglutide, dulaglutide, exenatide) to consume pumpkin seeds, and are there any dietary or gastrointestinal considerations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pumpkin Seeds and GLP-1 Receptor Agonists: Safety and Considerations

Patients taking GLP-1 receptor agonists can safely consume pumpkin seeds, and there is no documented drug-food interaction or contraindication between these medications and pumpkin seeds. In fact, pumpkin seeds may offer complementary nutritional benefits that address some of the deficiencies associated with GLP-1RA therapy.

No Direct Contraindications

The FDA labeling for GLP-1 receptor agonists (liraglutide, dulaglutide, semaglutide, tirzepatide) does not list pumpkin seeds or any specific dietary restrictions beyond standard fasting guidelines for procedures 1, 2. The primary concern with GLP-1RAs relates to delayed gastric emptying and its impact on oral medication absorption, not specific foods 1.

Potential Nutritional Benefits

Pumpkin seeds may actually provide beneficial micronutrients that GLP-1RA users commonly lack:

  • Iron supplementation: GLP-1RA users demonstrate 26-30% lower ferritin levels compared to other diabetes medications, with more than 60% consuming below estimated requirements for iron 3. Pumpkin seeds are a good source of iron and could help address this deficiency.

  • Protein content: Given that protein insufficiency contributes to lean mass loss in GLP-1RA users 3, the protein content of pumpkin seeds may be beneficial.

  • Glycemic benefits: Acute consumption of 65g of pumpkin seeds reduced postprandial glycemia by approximately 35% in normoglycemic adults 4, which could complement the glucose-lowering effects of GLP-1RAs.

Gastrointestinal Considerations

The main practical concern is timing and tolerance, not safety:

  • GLP-1RAs cause delayed gastric emptying and are associated with gastrointestinal adverse events including nausea (47-84% of users), vomiting, diarrhea, and constipation 5, 6.

  • All evaluated GLP-1RAs significantly increase nausea risk, with the highest risks seen with orforglipron, followed by exenatide, tirzepatide, semaglutide, and liraglutide 6.

  • Patients experiencing active gastrointestinal symptoms may find high-fiber, high-fat foods like pumpkin seeds less tolerable during symptom flares, but this is a comfort issue rather than a safety concern.

Practical Recommendations

Patients should:

  • Consume pumpkin seeds as part of a balanced diet without restriction 1, 2.

  • Consider pumpkin seeds as a nutritious option to help meet iron, protein, and calcium needs that are often inadequate in GLP-1RA users 3.

  • If experiencing significant gastrointestinal symptoms from GLP-1RA therapy, start with smaller portions of pumpkin seeds and increase as tolerated 5, 6.

  • Maintain adequate overall nutrition, as vitamin D deficiency occurs in 7.5% at 6 months and 13.6% at 12 months of GLP-1RA therapy, and vitamin D intake averages only 20% of recommendations 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.